Corvus Pharmaceuticals Inc (CRVS) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Corvus Pharmaceuticals Inc   (NASDAQ: CRVS)


Corvus Pharmaceuticals Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Corvus Pharmaceuticals Inc's ROI in the second quarter of 2026?
Corvus Pharmaceuticals Inc recorded a cumulative net loss of $-54 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -36.04%.

Within the Healthcare sector 399 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2142 to 3614.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 239.39 % 209.7 % 103.25 % 74.69 % 5.43 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 226 241 62 72 81
Return On Investment (TTM) -36.04 % -38.73 % -23.05 % -25.44 % -101.98 %
CRVS's Overall Ranking # 3614 # 2142 # 2771 # 3204 # 3236
Seq. Investment Change TTM 31.71 % 71.98 % 11.91 % 33.89 % 20.18 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -54 -44 -15 -15 -45

CRVS Company Profile >> Back to CRVS Roi Comparisons >> See Annual CRVS Return On Investment



Return On Investment CRVS's Ranking
Within: No.
Industry # 158
Sector # 400
Overall # 3614

Return On Investment Statistics
High Average Low
-7 %
-52.99 %
-190.93 %
(Mar 31 2021)   (Dec 31 2024)







Financial Statements
Corvus Pharmaceuticals Inc's II. Quarter Investments $ 226 Millions CRVS's Balance sheet
Corvus Pharmaceuticals Inc's II. Quarter Income $ -18 Millions Quarterly CRVS's Income Statement
CRVS's Income by Division See CRVS's Income by Division


CRVS Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 62 34 39 57 73
Y / Y Investment Growth 84.27 % -13.39 % -32.71 % -21.66 % -0.06 %
Net Income in Millions -15 -62 -27 -41 -6
Y / Y Net Income Growth - - - - -
Annual Return On Investment -24.75 % -185.92 % -69.87 % -71.85 % -8.17 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CRVS's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CRVS's Competitors
Subscribers only: Roi for Corvus Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for CRVS's Customers

Other Ratios
CRVS's Roa CRVS's Inventory Turnover Ratio CRVS's Growth Rates CRVS's Dividend Statistics
CRVS's Profitability Ratios CRVS's Asset Turnover Ratio CRVS's Dividend Growth
CRVS's Roe CRVS's Valuation Ratios CRVS's Financial Strength Ratios CRVS's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-08T13:43:31+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.